ripekg:work/10.1056%2Fnejme2110953Immune Thrombocytopenia Treatment |
prism:doi |
10.1056/nejme2110953 |
ripekg:work/10.1056%2Fnejme2110953Immune Thrombocytopenia Treatment |
dcterms:title |
Immune Thrombocytopenia Treatment |
ripekg:work/10.1056%2Fnejme2110953Immune Thrombocytopenia Treatment |
rdf:type |
node1 |
ripekg:work/10.1056%2Fnejme2110953Immune Thrombocytopenia Treatment |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1056%2Fnejme2110953Immune Thrombocytopenia Treatment |
rdf:type |
rdfs:Resource |
ripekg:work/10.1056%2Fnejme2110953Immune Thrombocytopenia Treatment |
rdf:type |
owl:Thing |
ripekg:work/10.1056%2Fnejme2110953Immune Thrombocytopenia Treatment |
rdf:type |
prov:Entity |
ripekg:work/10.1056%2Fnejme2110953Immune Thrombocytopenia Treatment |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1056%2Fnejme2110953Immune Thrombocytopenia Treatment |
owl:sameAs |
https://semopenalex.org/work/W3196535469 |
ripekg:work/10.1136%2Fbmj-2025-084314Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial |
http://purl.org/spar/cito/cites |
ripekg:work/10.1056%2Fnejme2110953Immune Thrombocytopenia Treatment |